Delcath Systems (DCTH) Competitors

CONMED (NYSE:CNMD) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Do insiders and institutionals believe in CNMD or DCTH?

61.1% of Delcath Systems shares are owned by institutional investors. 3.1% of CONMED shares are owned by company insiders. Comparatively, 17.4% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is CNMD or DCTH more profitable?

CONMED has a net margin of 10.13% compared to Delcath Systems' net margin of -150.70%. CONMED's return on equity of 14.31% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	10.13%	14.31%	5.64%
Delcath Systems	-150.70%	-338.16%	-104.02%

Which has more volatility and risk, CNMD or DCTH?

CONMED has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.

Does the MarketBeat Community favor CNMD or DCTH?

CONMED received 4 more outperform votes than Delcath Systems when rated by MarketBeat users. Likewise, 45.68% of users gave CONMED an outperform vote while only 27.50% of users gave Delcath Systems an outperform vote.

Company	Underperform	Outperform
CONMED	Outperform Votes 37 45.68%	Underperform Votes 44 54.32%
Delcath Systems	Outperform Votes 33 27.50%	Underperform Votes 87 72.50%

Do analysts recommend CNMD or DCTH?

CONMED currently has a consensus target price of $62.20, indicating a potential upside of 3.91%. Delcath Systems has a consensus target price of $22.75, indicating a potential upside of 26.60%. Given Delcath Systems' stronger consensus rating and higher possible upside, analysts plainly believe Delcath Systems is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Delcath Systems	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has better earnings and valuation, CNMD or DCTH?

CONMED has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.32B	1.41	$132.42M	$3.80	15.75
Delcath Systems	$53.85M	11.62	-$47.68M	-$0.50	-35.94

Does the media favor CNMD or DCTH?

In the previous week, CONMED and CONMED both had 5 articles in the media. CONMED's average media sentiment score of 1.31 beat Delcath Systems' score of 1.23 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Delcath Systems	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

CONMED beats Delcath Systems on 11 of the 17 factors compared between the two stocks.